Skip to main content
Clinical Trials/NCT06464900
NCT06464900
Not yet recruiting
Not Applicable

Effects of a Health Education Intervention Based on the Behaviour Change Wheel on Fear of Hypoglycemia in Patients With Type 2 Diabetes Mellitus: a Randomized Controlled Study

Yangzhou University1 site in 1 country90 target enrollmentJuly 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Health-Related Behavior
Sponsor
Yangzhou University
Enrollment
90
Locations
1
Primary Endpoint
Hypoglycemia fear survey
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

To examine the effects of a health Education Intervention based on the Behaviour Change Wheel (BCW) theory on fear of hypoglycemia and relevant outcomes of type 2 diabetic patients.

Detailed Description

In this study, eligible participants were randomized in a 1:1 ratio into an intervention group (health education based on BCW theory given on top of regular diabetes health education) and a control group (regular diabetes health education), with a 4-week intervention period and a 8-week follow-up period, for a total of 12 weeks.

Registry
clinicaltrials.gov
Start Date
July 2024
End Date
January 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Yangzhou University
Responsible Party
Principal Investigator
Principal Investigator

Zhao Yueqi

Principal Investigator

Yangzhou University

Eligibility Criteria

Inclusion Criteria

  • Comply with the 2020 Chinese guidelines for the prevention and treatment of type 2 diabetes mellitus;
  • Age ≥18 years;
  • Duration of diabetes mellitus ≥1 year;
  • FoH according to the elevated item endorsement criterion (E I criterion): ≥3 points on any item of the Hypoglycemic Fear-Worry Scale (HFS-WS);
  • Patients who have the ability to listen, read, write, walk, and cooperate to complete the study;
  • Patients who have a smart phone, and can skillfully use WeChat or telephone to communicate;
  • Voluntarily participate in this study and sign the informed consent form.

Exclusion Criteria

  • Patients with comorbid acute complications or other serious diseases or disorders of consciousness, such as diabetic hypertonic state, tumors, coma, etc;
  • Patients with comorbid psychiatric diseases or taking psychotropic drugs;
  • Patients who have recently or are participating in other studies on similar topics.

Outcomes

Primary Outcomes

Hypoglycemia fear survey

Time Frame: Baseline, 4 and 12 weeks post-intervention

Fear of hypoglycemia (FoH) was assessed using the Hypoglycemic Fear Survey Scale (HFS), which consists of two subscales, the Hypoglycemic Fear Survey- Behavioral Scale (HFS-BS) and the Hypoglycemic Fear Survey-Worry Scale (HFS-WS). (1) The HFS-BS scale has 19 entries, using a 5-point Likert scale, with scores ranging from 1 \~ 5 in descending order, and a total score of 15 \~ 95, with higher scores indicating more obvious hypoglycemic fearful behaviors in patients. (2) HFS-WS has 13 entries, which were scored using a 5-point Likert scale, with scores ranging from 0 to 4 from low to high, and a total score of 0 \~ 52. The higher the score, the higher the degree of fear of hypoglycemia in patients. The two subscale scores were added together, and the higher the total score, the more severe the fear of hypoglycemia.

Secondary Outcomes

  • Gold Rating(Baseline, 4 and 12 weeks post-intervention)
  • The self-management attitude scale for diabetes patients(Baseline, 4 and 12 weeks post-intervention)
  • The Patients Assessment Chronic Illness Care( PACIC)(Baseline, 4 and 12 weeks post-intervention)

Study Sites (1)

Loading locations...

Similar Trials